0 followers
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Stage
Employees
Links
Nickolay V. Kukekov
0 members
PharmaCielo
1 follower
Cannara Biotech
Aphria
3 followers
Khiron Life Sciences
Aurora Cannabis
2 followers
Discover companies